✦ LIBER ✦

Sensitization of multidrug-resistant colon cancer cells to doxorubicin encapsulated in liposomes

✍ Scribed by Stephane Oudard; Alain Thierry; Timothy J. Jorgensen; Aquilur Rahman

Publisher: Springer
Year: 1991
Tongue: English
Weight: 811 KB
Volume: 28
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00685532

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapeutic activity of silymarin c

Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells

✍ Valentina Colombo; Monica Lupi; Francesca Falcetta; Daniele Forestieri; Maurizio 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 512 KB

A novel doxorubicin-mitomycin C co-encap

A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells

✍ Adam J. Shuhendler; Richard Y. Cheung; Janet Manias; Allegra Connor; Andrew M. R 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 509 KB

Reversal of doxorubicin resistance by th

Reversal of doxorubicin resistance by the amiloride analogue EIPA in multidrug resistant human colon carcinoma cells

✍ Dr Antonella Pannocchia; Silvia Revelli; Giacomo Tamponi; Angelica Giorgianni; R 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 595 KB

Na+/H+ exchanger activity is increased i

Na+/H+ exchanger activity is increased in doxorubicin-resistant human colon cancer cells and its modulation modifies the sensitivity of the cells to doxorubicin

✍ Erica Miraglia; Daniele Viarisio; Chiara Riganti; Costanzo Costamagna; Dario Ghi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 141 KB 👁 1 views

## Abstract Multidrug resistant (MDR) tumor cells exhibit an altered pH gradient across different cell compartments, which favors a reduced intracellular accumulation of antineoplastic drugs and a decreased therapeutic effect. In our study, we have observed that the activity and expression of Na^+^

Chromatographic analysis and pharmacokin

Chromatographic analysis and pharmacokinetics of liposome-encapsulated doxorubicin in non-small-cell lung cancer patients

✍ Leanne Embree; Karen A. Gelmon; Andreas Lohr; Lawrence D. Mayer; Andrew J. Coldm 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 1024 KB

A sensitive and specific quantitative assay for total doxorubicin concentrations in plasma containing liposome-encapsulated doxorubicin hydrochloride (TLC D-99) was developed, with solvent extraction and reversed-phase high-performance liquid chromatography (HPLC). Separation of doxorubicin from its

Multidrug resistance modulators and doxo

Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells

✍ Anthony Lucci; Tie-Yan Han; Yong-Yu Liu; Armando E. Giuliano; Myles C. Cabot 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

## BACKGROUND. To provide insight for the development of more effective clinical agents, the authors attempted to elucidate the mechanisms of action of multidrug resistance (MDR) modulators. Previously, the authors found that MDR modulators blocked the conversion of ceramide to glucosylceramide in